[Lepra reaction and pregnancy].
Rodríguez-Pazos
L
L
Gómez-Bernal
S
S
Sánchez-Aguilar
D
D
Toribio
J
J
D001938:Brazil / Q000208:ethnology; D003622:Dapsone / Q000627:therapeutic use; D057210:Delayed Diagnosis; D005148:Facial Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D005260:Female; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D006229:Hand Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D006801:Humans; D006987:Hypesthesia / Q000209:etiology; D007111:Immunity, Cellular; D015441:Leprosy, Tuberculoid / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D016273:Occupational Exposure; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000382:microbiology*; D012293:Rifampin / Q000627:therapeutic use; D013030:Spain
D003622:Dapsone; D011241:Prednisone; D012293:Rifampin